Related Experiment Videos

Integrative network toxicology and machine learning identify AKR1C3 as a candidate functional target of cypermethrin

Houxi Xu1, Xiaoxiao Li2, Songxian Sun3

  • 1Key Laboratory of Acupuncture and Medicine Research of Ministry of Education, Nanjing University of Chinese Medicine, Nanjing, 210023, China.

Insights

Foodborne pesticides may contribute to colorectal cancer (CRC). This study identified AKR1C3 as a key gene linking pesticide exposure, like cypermethrin, to CRC-related cellular damage and oxidative stress.

Area of Science:

  • Environmental toxicology
  • Molecular biology
  • Computational toxicology

Background:

  • The link between foodborne pesticide residues and colorectal cancer (CRC) is not well understood.
  • Investigating molecular mechanisms is crucial for understanding pesticide-induced health risks.

Purpose of the Study:

  • To explore potential molecular connections between pesticides and CRC.
  • To identify specific genes and pathways involved in pesticide-induced cellular damage relevant to CRC.

Main Methods:

  • Integrated computational toxicology, network analysis, machine learning, and in vitro validation.
  • Evaluated toxicological properties of pesticides and predicted pesticide-target genes.
  • Identified hub genes and constructed a prognostic model for CRC.

Main Results:

  • Six hub genes, including AKR1C3, were identified and used to build a predictive CRC model.
  • AKR1C3 showed strong binding affinity with cypermethrin and deltamethrin.
  • Cypermethrin exposure reduced cell viability and AKR1C3 expression, while AKR1C3 overexpression offered partial protection.

Conclusions:

  • AKR1C3 is a potential functional target of cypermethrin in the context of CRC.
  • AKR1C3 may play a role in cypermethrin-induced cellular injury and oxidative stress relevant to colorectal cancer.
  • This study offers a framework for identifying molecular targets linking pesticide exposure to CRC.

Related Concept Videos

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...